Vedida 200 mg prašak za otopinu za infuziju 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

vedida 200 mg prašak za otopinu za infuziju

medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - vorikonazol - prašak za otopinu za infuziju - 200 mg - urbroj: svaka bočica sadrži 200 mg vorikonazola

AMIODARONE CLORIDRATO BIOINDUSTRIA LIM 150 mg/3 mL rastvor za injekciju/ infuziju 波斯尼亚和黑塞哥维那 - 克罗地亚文 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

amiodarone cloridrato bioindustria lim 150 mg/3 ml rastvor za injekciju/ infuziju

sanmed d.o.o. banja luka - амиодарон - rastvor za injekciju/ infuziju - 150 mg/3 ml - 3 ml rastvora za injekciju/infuziju sadrži:150 mg amiodaron hidrohlorida

Tacrocel 0,5 mg kapsule 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

tacrocel 0,5 mg kapsule

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - takrolimus hidrat - kapsula, tvrda - 0,5 mg - urbroj: 1 kapsula sadrži 0,5 mg takrolimusa u obliku takrolimus hidrata

Libtayo 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - karcinom, squamous cell - antineoplastična sredstva - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Cordarone 150 mg/3 ml koncentrat za otopinu za injekciju/infuziju 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

cordarone 150 mg/3 ml koncentrat za otopinu za injekciju/infuziju

sanofi winthrop industrie, 82, avenue raspail, gentilly, francuska - amiodaronklorid - koncentrat za otopinu za injekciju / infuziju - 150 mg/3 ml - urbroj: jedna ampula (3 ml otopine za injekciju/infuziju) sadrži 150 mg amiodaronklorida.

Vorikonazol Pliva 200 mg filmom obložene tablete 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

vorikonazol pliva 200 mg filmom obložene tablete

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - vorikonazol - filmom obložena tableta - 200 mg - urbroj: jedna tableta sadrži 200 mg vorikonazola

Melfalan Tillomed 50 mg prašak i otapalo za otopinu za injekciju/infuziju 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

melfalan tillomed 50 mg prašak i otapalo za otopinu za injekciju/infuziju

tillomed pharma gmbh, mittelstrasse 5/5a, schonefeld, njemačka - melfalanklorid - prašak i otapalo za otopinu za injekciju / infuziju - 50 mg - urbroj: jedna bočica praška sadrži 50 mg melfalana u obliku melfalanklorida.

ARYTMIL 50 mg/1 mL rastvor za injekciju 波斯尼亚和黑塞哥维那 - 克罗地亚文 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

arytmil 50 mg/1 ml rastvor za injekciju

doo ˝farmacija 2011˝ bihać - амиодарон - rastvor za injekciju - 50 mg/1 ml - jedna ampula sa 3 ml rastvora za injekciju sadrži 150 mg amiodaron hidrohlorida

Thiotepa Riemser 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastična sredstva - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Bexsero 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

bexsero

gsk vaccines s.r.l. - vanjska membrana везикулы od менингококк grupe b (soj 98/254 nc), рекомбинантный менингококк grupe u fhbp sintezu proteina, rekombinantnog менингококк grupe b nada protein, рекомбинантный менингококк grupe u nhba sintezu proteina - meningitis, meningokokal - meningokokna cjepiva - aktivna imunizacija protiv invazivnih bolesti uzrokovanih sojima neisseria meningitidis serogroup-b.